EAU Research Foundation NIMBUS Study Group: Recurrence Risk in patients with High Grade Non-Muscle Invasive Bladder Carcinoma in the Randomised Phase III Clinical Trial ‘NIMBUS’ stratified for EORTC and CUETO risk categories. A contemporary trend to less recurrences?

15 October 2020

Share this on your favourite network: